Trial Profile
Phase II study of S-1 combined with irinotecan in patients with advanced colorectal cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Mar 2009
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Irinotecan
- Indications Colorectal cancer
- Focus Therapeutic Use
- 02 Mar 2009 New trial record.